| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.06 |